36 results on '"Ivanovski, K."'
Search Results
2. Achievements in CKD-MBD guidelines targets: is there a progress in the implementation practice?
- Author
-
Spasovski, G., Zdravkovska, V., Zabzun, M., Antarorov, R., Ivanovski, K., Janakievska, P., Neskovski, J., Karceva-Sarajlia, E., Panova, B., Petrovska, T., Zulbeari, L., Masin-Spasovska, J., Taleska-Matovska, N., and Gelev, S.
- Published
- 2012
- Full Text
- View/download PDF
3. The role of salivary antioxidants in the protection of oral tissues
- Author
-
Dirjanska, K., primary, Ivanovski, K., additional, Poposki, B., additional, Micevski, B., additional, Gligurova, I., additional, and Asani, R., additional
- Published
- 2021
- Full Text
- View/download PDF
4. The connection between oral health and salivary levels of total proteins, calcium and phosphates.
- Author
-
Ristoska, S, primary, Ivanovski, K, additional, Pesevska, S, additional, Mindova, S, additional, Stefanovska, E, additional, Rendjova, V, additional, and Eftimoska, M, additional
- Published
- 2021
- Full Text
- View/download PDF
5. Tips and advices when planning and conducting the prosthodontic treatment in pediatric patients: letter to the editorial board
- Author
-
Bajraktarova Valjakova, E, primary, Korunoska Stevkovska, V, additional, Sotirovska Ivkovska, A, additional, Bajraktarova Misevska, C, additional, Elenchevski, S, additional, Georgieva, S, additional, and Ivanovski, K, additional
- Published
- 2020
- Full Text
- View/download PDF
6. Prevalence of oral candidiasis in complete dentures wearers
- Author
-
Tmava-Dragusha, A., primary, Shala, K., additional, Ivanovski, K., additional, Dirjanska, K., additional, Ristoska, S., additional, and Elenchevski, S., additional
- Published
- 2020
- Full Text
- View/download PDF
7. DIAGNOSIS AND TREATMENT OF RENAL OSTEODYSTROPHY IN REP. OF MACEDONIA: P48
- Author
-
Spasovski, G., Gelev, S., Zdravkovska, V., Tomanovski, V., Trpenovski, L., Ivanovski, K., Bajraktarova, T., Janakievska, P., Damjanovski, M., Neskovski, J., Karceva-Sarajlia, E., Petrovska, T., Filkovska, K., Matovic, S., Luseva, V., Jordanovski, D., and Zafirovska, M.
- Published
- 2005
8. Clinical effects of Fidelis III ND:YAG laser in periodontal disease treatment.
- Author
-
Buchkovska, A., primary, Georgieva, S., additional, Peshevska, S., additional, Ivanovski, K., additional, and Pandilova, M., additional
- Published
- 2019
- Full Text
- View/download PDF
9. Achievements in CKD-MBD guidelines targets: is there a progress in the implementation practice?
- Author
-
Spasovski, G., primary, Zdravkovska, V., additional, Zabzun, M., additional, Antarorov, R., additional, Ivanovski, K., additional, Janakievska, P., additional, Neskovski, J., additional, Karceva-Sarajlia, E., additional, Panova, B., additional, Petrovska, T., additional, Zulbeari, L., additional, Masin-Spasovska, J., additional, Taleska-Matovska, N., additional, and Gelev, S., additional
- Published
- 2011
- Full Text
- View/download PDF
10. INTERPROXIMAL PLAQUE CONTROL IN PATIENTS WITH FIXED ORTHODONTIC APPLIANCES.
- Author
-
Stefanovsk, E., Ivanovski, K., Atanasovska-Stojanovska, A., Zabokova-Bilbilova, E., and Zendeli-Bedzeti, L.
- Subjects
DENTAL plaque ,ORTHODONTIC appliances ,ORAL hygiene ,GINGIVAL hyperplasia ,TOOTHBRUSHES ,PREVENTION - Abstract
The aim of the study was to determine the influence of an interproximal cleaning on the oral hygiene status and to compare the plaque control effectiveness of an inter-proximal brushing in combination with mechanical tooth-brushing at 30 right-handed patients with brackets in the upper and in the lower arch. 15 patients used inter-proximal brushes combined with manual tooth-brushing, twice a day in all quadrants, while other 15 patients maintained oral hygiene with manual tooth-brushing technique only. Dental plaque index (DPI), Approximal plaque index (API) and Gingival bleeding index (GBI) were performed one week after the orthodontic treatment, when patients were instructed how to maintain oral hygiene and inter-dental hygiene, and also 4 weeks after orthodontic treatment. According to the results presenting statistically significant differences in the mean values of DPI, GBI and API, among the examine groups, (p <0, 00001), the improvements of oral hygiene could be interpreted as an outcome of the instruction and motivation given to the patients with fixed orthodontic appliances. [ABSTRACT FROM AUTHOR]
- Published
- 2014
11. XEROSTOMIA AND SALIVARY LEVELS OF GLUCOSE AND UREA IN PATIENTS WITH DIABETES.
- Author
-
Ivanovski K., Naumovski V., Kostadinova M., Pesevska S., Drijanska K., and Filipce V.
- Subjects
- *
SALIVA , *DIABETES , *XEROSTOMIA , *SALIVARY gland diseases , *GLUCOSE , *UREA - Abstract
Examination of the composition of saliva in patients with diabetes may be useful for understanding why oral manifestations occur and how they should be treated. The purpose of this study was to determine the degree of severity of xerostomia, salivary concentrations of glucose and urea in patients with insulin-dependent diabetes, and to determine the correlation between xerostomia and salivary glucose levels. For the realization of this goal, the study included 60 patients of both sexes aged 30–70 years. The sample was divided into two groups. The first, experimental, group consisted of 30 patients who had insulin-dependent diabetes mellitus. The control group consisted of 30 subjects who were not suffering from diabetes. To determine the degree of severity of xerostomia among all respondents a questionnaire recommended by Carda was used. From all patients in both the control and experimental group, total saliva was collected for 10 minutes for biochemical analysis in accordance with the recommendations of Navazesh. Salivary glucose was determined by using the enzymatic method with a hexokinase (mmol/l), and salivary urea by using the kinetic method with urease and glutamate dehydrogenase (mmol/l). Varying degrees of xerostomia were noticed in 80% of the experimental group and only 10% of the control group. In diabetics, we found significantly higher levels of urea (2.36 mmol/l) and glucose (0.022 mmol/l) in the saliva compared with the values of these parameters (1.48 mmol/l, 0017 mmol/l) in the control group. Based on these results, we concluded that diabetes is a disease that causes xerostomia and there is a significant correlation between the degree of xerostomia and the salivary level of glucose. [ABSTRACT FROM AUTHOR]
- Published
- 2012
12. Periodontal treatment with a low-level diode laser: clinical findings.
- Author
-
Angelov N, Pesevska S, Nakova M, Gjorgoski I, Ivanovski K, Angelova D, Hoffmann O, and Andreana S
- Abstract
This study assessed the effects of low-level laser treatment in combination with scaling and root planing (SRP) in patients with periodontitis. Sixty subjects with chronic advanced periodontitis were assigned randomly to three treatment groups (n = 20) after collecting gingival clinical parameters. Group A received SRP on a single quadrant per day for four consecutive days; on the fifth day, all quadrants were rescaled. Group B received the same treatment as Group A, followed by laser application for five days. Group C received the same treatment as Group B but the laser treatment was administered for a total of 10 days. For Groups B and C, a low-level diode laser (630 to 670 nm) was used. The plaque index, gingival index, and sulcular bleeding index were recorded for all groups.For all clinical parameters, all three groups reported statistically significant differences (p < 0.005) compared to baseline data. Compared to Group A, Groups B and C showed statistically significant improvement for all clinical parameters. These findings suggest that a low-level diode laser can have a beneficial effect for treating inflammatory chronic advanced periodontitis. [ABSTRACT FROM AUTHOR]
- Published
- 2009
13. Psychological profile in oral lichen planus.
- Author
-
Ivanovski K, Nakova M, Warburton G, Pesevska S, Filipovska A, Nares S, Nunn ME, Angelova D, and Angelov N
- Abstract
AIM: Oral lichen planus (OLP) is an oral lesion with an enigmatic etiology. To explore the possibility of psycho-somatization, we evaluated the psychological personality profiles of OLP patients. METHODS: Twenty patients with reticular; 20 with erosive form of OLP, and 25 controls were tested with the psychological Minnesota Multiphasic Personality Inventory (MMPI)-202 test. Eight clinical scales (hypochondriasis, depression, hysteria, psychopathic deviate, paranoia, psychasthenia, schizophrenia, and hypomania) as well as cortisol level, CD3, CD4, CD8, and CD16 markers by group were compared. Psychosomatization was evaluated by the use of internalization ratio (IR) Index. RESULTS: A characteristic MMPI profile was noted in the OLP groups with high IR index value. Significant differences among the groups were detected for cortisol, CD4, CD8, and CD16 counts. Mean values for hypochondriasis, depression, and hysteria were all significantly different with significantly higher mean scores for both reticular and erosive OLP subjects compared with controls. CONCLUSIONS: Prolonged emotive stress in many OLP patients may lead to psychosomatization and may contribute to the initiation and clinical expression of this oral disorder. Clinical significance: If additional research involving a larger and more diverse sample of patients confirms these findings, clinical trials will be needed to determine whether adjunctive psychological intervention provides a benefit in treating patients with OLP. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
14. The impact of fixed orthodontic appliances on periodontal health to young patients.
- Author
-
Georgieva, S., Ivanovski, K., Pandilova, M., Stefanovska, E., and Korunoska-Stevkovska, V.
- Subjects
ORTHODONTIC appliances ,ORAL hygiene ,DENTAL plaque - Abstract
Introduction: The purpose of this article is through clinical trials which involve accumulation of dental plaque and gingival inflammation to follow through the impact of fixed orthodontic appliances on periodontal health. Material and method: The study has included 30 patients aged 12 to 18 years, divided into two groups: experimental group (with fixed orthodontic appliances) and control group (without fixed orthodontic appliances). The degree of accumulation of dental plaque was assessed by using Ramfjord index, and gingival inflammation by the index of Loe Sillness. Results: The results indicate a high percentage of dental plague and gingival inflammation in experimental group compared to the control group. These results give us the right to conclude that young patients during orthodontic treatment are at a high risk of developing gingival inflammation, determined by plague accumulation, with all the consequences on their periodontal health. Conclusion: The use of all oral hygiene methods is the best way to prevent any unwanted consequences on periodontal health among young patients during orthodontic treatment. The number of patients that decide to solve their functional and aesthetic issues with the help of fixed orthodontic appliances is getting bigger. The young population is where we most often use fixed orthodontic appliances. Despite all the positive values of this method in orthodontic treatment that is being used more often every day, it can be the cause for unwanted consequences. Primarily, we are talking about inflammation of the gingiva, and decalcification of the teeth around the brackets that is a serious problem that can compromise the results of the treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2015
15. Dialysis in Adults in Year 2000 in the Republic of Macedonia
- Author
-
Polenakovic, M.H., Sikole, A., Grozdanovski, R., Amitov, V., Stojkovski, Lj., Oncevski, A., Grcevska, L., Dzikova, S., Cakalaroski, K., Bogdanovska, S., Gerasimovska, V., Gerasimovska, B., Milovanceva, M., Stojceva-Taneva, O., Krstanovski, B., Kovaceski, S., Serijat, M., Mustafa, Z., Capova, O., Bajalska, A., Nikolovski, A., Filipovic, R., Neskovski, J., Selja, Lj., Janakievska, P., Lamova, K., Hristova, V., Sarajlija, E. Karceva, Romeo, M., Mitrevski, Z., Ivanovski, K., Dimitrov, S., Velinova, B., and Panova, B.
- Abstract
1,019 adult patients with terminal renal failure were treated with dialysis (D) in the first part of the year 2000 in the Republic of Macedonia. 1,010 patients (99%) were treated with chronic intermittent (maintenance) hemodialysis (HD) while nine patients (1%) were on continuous ambulatory peritoneal dialysis (CAPD). For the children, a special peritoneal dialysis program was developed; 509 patients per million of the population (PMP) were on dialysis.The Republic of Macedonia is, therefore, among those central and eastern European countries with a higher PMP number in the treatment of end-stage renal disease, following Croatia, the Czech Republic and Slovenia.The patients were treated at 18 Centers in a network of HD Centers at a distance of 30–50 km. from their place of residence in order to facilitate their access to treatment and to work. All patients who have had symptoms indicating need for treatment with D were accepted for treatment. The government payed all the expenses of the treatment and the salaries of the staff. 56% were male and 44% were female patients. The youngest patient was aged 9 and the oldest was 82 years old. There has been an increase in the age of the patients on D as well as an increase in their number. In 1993 we had 727 patients being treated with D, and now we have 1,019 with a constant increase in the number of patients with ESRD and a need for D and renal transplantation. Mortality per year at the different Centers ranged from 8–19% in 1999 and the average is 12%.Glomerulonephritis (GN) – both primary and secondary – is the main cause of renal failure (RF) in some Centers up to 45%. Tubulo-interstitial disease follows GN. ADPKD patients constitute 9.4% with a difference among the Centers of 3–29%, and diabetic nephropathy is found in 10%, 5–15% in different Centers. 11–61% of patients have an unknown etiology.352 patients are on treatment with human recombinant erythropoietin (rhuEPO) – in some Centers up to 60%. The mode of application was subcutaneous and the initial dose is 20 U/kg body weight and the mean maintenance dose of EPO per patient weekly is 4,000 U.The Cimino-Brescia arteriovenous fistula is being applied as a standard vascular access. The survival rate of our patients treated with maintenance HD at 5 years was 58%. CAPD and particularly renal transplantation are to be further developed as alternative methods in treating terminal renal failure.
- Published
- 2002
- Full Text
- View/download PDF
16. Presence of caries with different levels of oral hygiene
- Author
-
Sonja Apostolska, Rendzova, V., Ivanovski, K., Peeva, M., and Elencevski, S.
17. Effects of smoking to the lipid profile in patients with periodontal disease
- Author
-
Mindova, S., Ivanovski, K., Pesevska, S., Maja Pandilova, Georgieva, S., Stefanovska, E., Ristoska, S., Dirjanska, K., and Koneski, F.
18. The impact of antihypertensive medications on quantitative and qualitative characteristics of Saliva
- Author
-
Ivanovski, K., Snezana Pesevska, Ristoska, S., Dirjanska, K., Mindova, S., Pandilova, M., Georgieva, S., Stefanovska, E., Filipce, V., Apostolska, S., and Eftimoska, M.
19. Clinical and histological analyzes of the response of the pulp after its direct capping with Calxyl, MTA and Biodentine
- Author
-
Eftimoska, M., Sonja Apostolska, Rendzhova, V., Gjorgievska, E., Stevanovic, M., Ivanovski, K., Jankulovska, M., Elenchevski, S., Pavlevska, M., and Dimkov, A.
20. Bacterial contamination of the toothbrushes
- Author
-
Peševska, S., Ivanovski, K., Mindova, S., Kaftandzieva, A., Ristoska, S., Stefanovska, E., Maja Pandilova, Georgieva, S., Dirjanska, K., Janeva, I. P., and Koneski, F.
21. SEM evaluation of dentin surface after different types of caries removal
- Author
-
Apostolska, S. M., Rendzova, V. P., Eftimoska, M., Elencevski, S. M., Stevanovic, M. M., Ivanovski, K., Jankulovska, M., Pavlevska, M., Aleksandar Dimkov, and Gjorgievska, E.
22. Cytomorphological analysis of burning mouth syndrome among individuals with hypochromic anemia
- Author
-
Georgieva, S., Pandilova, M., Ivanovski, K., Pesevska, S., Stefanovska, E., Mindova, S., Ristoska, S., Dirijanska, K., and Filip Koneski
23. The use of low level laser therapy for pain reduction during fixed orthodontic treatment
- Author
-
Snezana Pesevska, Maneva, M., Ivanovski, K., Pandilova, M., Georgieva, S., Mindova, S., Ristoska, S., Stefanovska, E., Cuckova, G. C., Apostolova, G., Apostolova, E., and Koneski, F.
24. Salivary Markers in Patients with Chronic Kidney Disease.
- Author
-
Poposki B, Ivanovski K, Stefanova R, Dirjanska K, Rambabova-Bushljetik I, Ristovski V, and Risteska N
- Subjects
- Humans, Creatinine, Saliva, Urea, Renal Insufficiency, Chronic diagnosis
- Abstract
Aim of the study : To determine the possibility of using saliva as a diagnostic and prognostic tool for screening and monitoring kidney function. Methods : This study included 32 patients with different stages of chronic kidney disease (CKD) and 20 healthy examinees for the control group. Saliva was collected using the spitting method, and on the same day blood was also drawn from the examinees to determine serum concentrations of urea and creatinine. The salivary values of uric acid, urea, creatinine and albumin were determined with a spectrophotometer, as well as the serum concentrations of urea and creatinine. Results : Our results showed a statistically significant positive correlation between salivary and serum levels of urea and creatinine in patients with CKD (Pearson's correlation coefficient for urea was r =0.6527, p = 0.000, while for creatinine it was r = 0.5486, p = 0.001). We detected a statistically significant positive correlation between the salivary levels of urea and the clinical stage of CKD (r = 0.4667, p = 0.007). We did not register a significant correlation between the salivary levels of creatinine and the clinical stage of CKD (r = 0.1643, p = 0.369). Conclusion : Salivary urea is a valid marker for determining kidney function and a potential salivary marker for screening and monitoring kidney function. Salivary creatinine can be used as a qualitative marker, only indicating the existence of a disease., (© 2023 Bojan Poposki et al., published by Sciendo.)
- Published
- 2023
- Full Text
- View/download PDF
25. Has the COVID-19 pandemic converged across countries?
- Author
-
Awaworyi Churchill S, Inekwe J, and Ivanovski K
- Abstract
The outbreak of COVID-19 has induced economic and financial disruptions to global economies, consistent with those experienced during previous episodes of economic or financial crises. This study offers a critical perspective into the spread of the virus by investigating the convergence patterns of COVID-19 across 155 countries from March 2020 to August 2021. The club clustering algorithm is used to verify the convergence patterns of infection and death rates in these countries. The findings show that full panel convergence cannot be achieved indicating the presence of sub-convergent clusters. Cluster formation for death rates includes the Americas, Africa, the Middle East, and Asia, among others. To understand the factors driving these results, we analyse the determinants of the convergence process of COVID-19. The probability of belonging to a cluster with higher death intensity increases with being above the age of 65, poverty, and for female smokers while handwashing shows beneficial effect on case intensity., Competing Interests: Conflict of interestThere is no conflict of interest for any of the authors., (© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.)
- Published
- 2023
- Full Text
- View/download PDF
26. Diagnostic and Prognostic Markers of Periodontal Disease.
- Author
-
Risteska N, Poposki B, Ivanovski K, Dirjanska K, Ristoska S, and Saveski M
- Subjects
- Aspartate Aminotransferases, Humans, Prognosis, Saliva, Periodontal Diseases diagnosis, Periodontitis
- Abstract
Aim of the study: The aim of this study is to determine the values of salivary enzyme biomarkers (alkaline phosphatase - ALP, aspartate aminotransferase - AST and lactate dehydrogenase - LDH) in subjects with healthy and diseased periodontium and to investigate the possibility of using these salivary enzymes as diagnostic and prognostic markers. Methods: We collected saliva with the spitting method from all examinees in the morning, using the recommendations provided by Navazesh. The values of the enzymes in saliva were determined spectro-photometrically, with the following methods: ALP-IFCC, AST-IFCC, LDH-PYRUVATE. IGI Silness-Löe was used to determine the presence of gingival inflammation, and to determine the presence of clinically manifest periodontitis, we determined the clinical loss of periodontal attachment with a graduated periodontal probe. For statistical purposes, we used the method of ANOVA Chi Square and Student's t-test. Results: The difference in the average salivary AST and LDH values between the first and the second group, as well between the first and third group is statistically significant (p < 0.000). The difference in the average salivary AST and LDH values between the examinees with gingivitis and the examinees with clinically manifest periodontal disease is statistically insignificant (p < 0.485101 for AST, p < 0.816665 for LDH). The difference in the average salivary levels of ALP between the three groups is statistically significant (p < 0.000). Conclusion: The salivary levels of AST, LDH, and ALP can be used as diagnostic markers, while ALP can also be used as a prognostic marker for periodontal disease., (© 2021 Ioannis Chrysikos, published by Sciendo.)
- Published
- 2021
- Full Text
- View/download PDF
27. Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high-risk multiple myeloma.
- Author
-
Biran N, Gourna Paleoudis E, Feinman R, Vesole DH, Zenreich J, Wang S, Ahn J, Bansal M, Rowley S, Donato M, Pecora AL, Richter J, Anand P, McBride L, Ivanovski K, Korngold R, and Siegel DS
- Subjects
- Antibodies, Monoclonal, Humanized adverse effects, Antineoplastic Combined Chemotherapy Protocols adverse effects, Dexamethasone adverse effects, Follow-Up Studies, Humans, Lenalidomide adverse effects, Multiple Myeloma therapy, Stem Cell Transplantation, Transplantation, Autologous, Antibodies, Monoclonal, Humanized therapeutic use, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Dexamethasone therapeutic use, Lenalidomide therapeutic use, Multiple Myeloma drug therapy
- Published
- 2021
- Full Text
- View/download PDF
28. Hydrofluoric Acid: Burns and Systemic Toxicity, Protective Measures, Immediate and Hospital Medical Treatment.
- Author
-
Bajraktarova-Valjakova E, Korunoska-Stevkovska V, Georgieva S, Ivanovski K, Bajraktarova-Misevska C, Mijoska A, and Grozdanov A
- Abstract
Background: Hydrofluoric acid is a commonly used chemical in many industrial branches, but it can also be found as an ingredient in household products such as cleaning agents. Possessing high corrosive potential, HF acid causes burns and tissue necrosis, while when absorbed and distributed through the bloodstream, its extremely high toxic potential is expressed. Acute symptoms are often followed by pain, particularly in the case of skin burns, which intensiveness does not often correlate with the expressiveness of the clinical findings. Even exposure to low-concentrated solutions or gasses, or low-doses of high-concentrated acid, may provoke delayed systemic disorder which may eventually have a lethal outcome., Aim: Therefore, having information regarding the possible hazardous effects of hydrofluoric acid usage, a variety of symptoms, as well as a treatment approach, is of great importance in the case of HF exposure., Methods: Available scientific articles published in literature databases, scientific reports and governmental recommendations from the internet websites, written in English, using the following search terms "Hydrofluoric acid, skin burns, eye injury, ingestion, inhalation, systemic toxicity, decontamination, antidote, medical treatment" have been reviewed., Results: This review is useful not only for physicians but for everyone who may come in contact with a person exposed to HF acid., Conclusion: It highlights the mechanism of action, presents the acute and chronic symptoms, personal and general protective measures and devices that should be used, as well as decontamination procedures, immediate, antidote and hospital medical treatment.
- Published
- 2018
- Full Text
- View/download PDF
29. The effect of low-level diode laser on COX-2 gene expression in chronic periodontitis patients.
- Author
-
Pesevska S, Gjorgoski I, Ivanovski K, Soldatos NK, and Angelov N
- Subjects
- Adult, Aged, Analysis of Variance, Female, Humans, Male, Middle Aged, Chronic Periodontitis enzymology, Chronic Periodontitis surgery, Gene Expression Regulation, Enzymologic radiation effects, Lasers, Semiconductor therapeutic use
- Abstract
Adjunctive treatments to scaling and root planing (SRP) such as lasers, have been utilized in the treatment of chronic periodontitis, mainly aiming to suppress and eliminate the bacteria, as well as enhancing the healing response. Eighty gingival papilla biopsy samples were obtained from 60 patients diagnosed with chronic advanced periodontitis; randomly assigned to three treatment groups (n = 20), as well as 20 subjects with no periodontal disease [group A]. Group B received SRP on a single quadrant/day for four consecutive days. On day 5, all quadrants were rescaled. Groups C and D received the same treatment as group B plus laser application with the low-level diode laser (630-670 nm, 1.875 J/cm2) for five and ten consecutive days, respectively. Papilla biopsies were obtained from subjects and evaluated by RT-PCR for expression of COX-2. The values in the control group were 0.028 0.014 and baseline values for the examined groups were 0.16 0.18. Significantly decreased level of COX-2 expression for groups C and D was found after treatment, while lowest average expression was found in the group that had the 10 laser treatments supplemental to SRP (0,035 0,014). The results of this study show suppression of COX-2 in gingival tissue after low-level laser treatment as adjunct to SRP.
- Published
- 2017
- Full Text
- View/download PDF
30. A phase IIb trial of vorinostat in combination with lenalidomide and dexamethasone in patients with multiple myeloma refractory to previous lenalidomide-containing regimens.
- Author
-
Sanchez L, Vesole DH, Richter JR, Biran N, Bilotti E, McBride L, Anand P, Ivanovski K, and Siegel DS
- Subjects
- Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Disease-Free Survival, Female, Humans, Lenalidomide, Male, Middle Aged, Multiple Myeloma complications, Remission Induction, Salvage Therapy adverse effects, Thalidomide administration & dosage, Treatment Outcome, Vorinostat, Dexamethasone administration & dosage, Hydroxamic Acids administration & dosage, Multiple Myeloma drug therapy, Salvage Therapy methods, Thalidomide analogs & derivatives
- Abstract
Clinical trials of vorinostat, a Class I/II histone deacetylase inhibitor, in combination with proteasome inhibitors and immunomodulatory agents have shown activity in relapsed/refractory multiple myeloma. This phase IIb, open-label, single-institution study evaluated the efficacy of vorinostat in combination with lenalidomide and dexamethasone in lenalidomide-refractory patients. Patients were considered lenalidomide-refractory if they had no clinical response (
- Published
- 2017
- Full Text
- View/download PDF
31. Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
- Author
-
Vesole DH, Bilotti E, Richter JR, McNeill A, McBride L, Raucci L, Anand P, Bednarz U, Ivanovski K, Smith J, Batra V, Aleman A, Sims T, Guerrero L, Mato A, and Siegel DS
- Subjects
- Aged, Antineoplastic Combined Chemotherapy Protocols adverse effects, Dexamethasone administration & dosage, Dexamethasone adverse effects, Disease-Free Survival, Female, Humans, Hydroxamic Acids administration & dosage, Hydroxamic Acids adverse effects, Lenalidomide, Male, Middle Aged, Oligopeptides administration & dosage, Oligopeptides adverse effects, Survival Rate, Thalidomide administration & dosage, Thalidomide adverse effects, Thalidomide analogs & derivatives, Vorinostat, Antineoplastic Combined Chemotherapy Protocols administration & dosage, Multiple Myeloma drug therapy, Multiple Myeloma pathology
- Abstract
Research has shown that proteasome inhibitors (e.g., carfilzomib), immunomodulatory agents (e.g., lenalidomide), histone deacetylase inhibitors (e.g., vorinostat) and corticosteroids (e.g., dexamethasone) have synergistic anti-multiple myeloma (MM) activity. This phase I dose-escalation study evaluated a regimen combining carfilzomib, lenalidomide, vorinostat and dexamethasone (QUAD) in patients with relapsed and/or refractory MM. Seventeen patients received carfilzomib (15, 20, or 20/27 mg/m(2) ; 30-min infusion; days 1, 2, 8, 9, 15, 16), lenalidomide (15 or 25 mg; days 1-21), vorinostat (300 or 400 mg; days 1-7, 15-21), and dexamethasone (40 mg; days 1, 8, 15, 22) in 28-d cycles. No dose-limiting toxicities were observed; the maximum tolerated dose was not reached. The maximum administered dose was carfilzomib 20/27 mg/m(2) , lenalidomide 25 mg, vorinostat 400 mg, and dexamethasone 40 mg. Common grade ≥3 adverse events included neutropenia (53%), thrombocytopenia (53%) and anaemia (41%). The overall response rate was 53%: 12% of patients achieved a very good partial response (PR) and 41% of patients achieved a PR. At a median follow-up of 10 months, median progression-free survival was 12 months and median overall survival was not reached. Treatment with QUAD was feasible and had encouraging activity in patients with relapsed and/or refractory MM., (© 2015 John Wiley & Sons Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
32. Effect of laser on TNF-alpha expression in inflamed human gingival tissue.
- Author
-
Pesevska S, Nakova M, Gjorgoski I, Angelov N, Ivanovski K, Nares S, and Andreana S
- Subjects
- Adult, Aged, Chronic Periodontitis therapy, Combined Modality Therapy, Female, Gingiva radiation effects, Humans, Male, Middle Aged, Root Planing, Chronic Periodontitis metabolism, Dental Scaling, Gingiva metabolism, Low-Level Light Therapy methods, Tumor Necrosis Factor-alpha metabolism
- Abstract
This study sought to evaluate the effect of low-level laser treatment combined with scaling and root planing (SRP) on gingival tissue levels of TNF-alpha in subjects with periodontal disease. Eighty gingival papilla biopsy samples were obtained from 60 patients diagnosed with chronic advanced periodontitis; randomly assigned to three treatment groups (n = 20), as well as 20 subjects with no periodontal disease (group A). Group B received SRP on a single quadrant/day for four consecutive days. On day 5, all quadrants were rescaled. Groups C and D received the same treatment as group B plus laser application with the low-level diode laser (630-670 nm, 1.875 J/cm(2)) for five and ten consecutive days, respectively. Papilla biopsies were obtained from subjects and evaluated by ELISA for levels of TNF-alpha. The values in the control group were 5.2 ± 3.21 pg/mg and baseline values for the examined groups were 46.01 ± 16.69. Significantly decreased level of TNF-alpha for groups C and D was found after treatment, while group B demonstrated reduction of TNF-alpha of 31.34%. The results of this study show suppression of TNF-alpha in gingival tissue after low-level laser treatment as adjunct to SRP. Data may suggest beneficial anti-inflammatory effects of the laser treatment when used as adjunctive periodontal treatment.
- Published
- 2012
- Full Text
- View/download PDF
33. Xerostomia and salivary levels of glucose and urea in patients with diabetes.
- Author
-
Ivanovski K, Naumovski V, Kostadinova M, Pesevska S, Drijanska K, and Filipce V
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Diabetes Mellitus, Type 1 metabolism, Glucose metabolism, Saliva chemistry, Urea metabolism, Xerostomia metabolism
- Abstract
Examination of the composition of saliva in patients with diabetes may be useful for understanding why oral manifestations occur and how they should be treated. The purpose of this study was to determine the degree of severity of xerostomia, salivary concentrations of glucose and urea in patients with insulin-dependent diabetes, and to determine the correlation between xerostomia and salivary glucose levels. For the realization of this goal, the study included 60 patients of both sexes aged 30-70 years. The sample was divided into two groups. The first, experimental, group consisted of 30 patients who had insulin-dependent diabetes mellitus. The control group consisted of 30 subjects who were not suffering from diabetes. To determine the degree of severity of xerostomia among all respondents a questionnaire recommended by Carda was used. From all patients in both the control and experimental group, total saliva was collected for 10 minutes for biochemical analysis in accordance with the recommendations of Navazesh. Salivary glucose was determined by using the enzymatic method with a hexokinase (mmol/l), and salivary urea by using the kinetic method with urease and glutamate dehydrogenase (mmol/l). Varying degrees of xerostomia were noticed in 80% of the experimental group and only 10% of the control group. In diabetics, we found significantly higher levels of urea (2.36 mmol/l) and glucose (0.022 mmol/l) in the saliva compared with the values of these parameters (1.48 mmol/l, 0017 mmol/l) in the control group. Based on these results, we concluded that diabetes is a disease that causes xerostomia and there is a significant correlation between the degree of xerostomia and the salivary level of glucose.
- Published
- 2012
34. Presence of caries with different levels of oral hygiene.
- Author
-
Apostolska S, Rendzova V, Ivanovski K, Peeva M, and Elencevski S
- Subjects
- Adult, Age Factors, Aged, Female, Humans, Male, Middle Aged, Oral Hygiene methods, Republic of North Macedonia epidemiology, Risk Factors, Dental Caries diagnosis, Dental Caries epidemiology, Dental Caries etiology, Dental Caries prevention & control, Saliva microbiology, Streptococcus isolation & purification
- Abstract
The objective of this abstract is to examine the presence of caries in the adult population with different levels of oral hygiene; to examine the concentration of Streptococcus Mutans in saliva of patients with different levels of oral hygiene; to examine the correlation among Streptococcus Mutans, caries and level of oral hygiene. This examination was made on 50 (fifty) patients, both male and female, at the age of 20 to 65. The examinees were split into 5 groups. The examinations and sampling were done randomly at the Department of Cariology and Endodontics at the Faculty of Dental Medicine in Skopje. The microbiological researches were made at the Institute of Microbiology and parasitology at the Faculty of Medicine in Skopje. The examination of all patients was made according to a unique methodology. The results obtained indicate that the Plaque index level and the number of Streptococcus Mutans in saliva (CFU) are correlated to the number of carious teeth in all age groups except for Group V (61-65) where the Plaque index level and the level of Streptococcus Mutans in saliva were much higher compared to the number of carious teeth (51-99 and >100 CFU), particularly for examinees with prosthesis. Initial enamel caries was dominant in patients up to the age of 50, and for those older than 50 surface root caries was dominant. Initial caries was present in 28.62% of Group I and was 5.66% in Group V, unlike the root surface caries in Group 1, with 1.14%, and Group 5 with 28.30%.
- Published
- 2011
35. Dentinal hypersensitivity following scaling and root planing: comparison of low-level laser and topical fluoride treatment.
- Author
-
Pesevska S, Nakova M, Ivanovski K, Angelov N, Kesic L, Obradovic R, Mindova S, and Nares S
- Subjects
- Adult, Dentin Sensitivity etiology, Dentin Sensitivity physiopathology, Humans, Lasers, Semiconductor therapeutic use, Pain drug therapy, Pain radiotherapy, Dental Scaling adverse effects, Dentin Sensitivity drug therapy, Dentin Sensitivity radiotherapy, Fluorides, Topical therapeutic use, Low-Level Light Therapy, Root Planing adverse effects
- Abstract
The aim of this study is to compare the effectiveness of low-level laser irradiation to traditional topical fluoride treatment for treatment choices of dentinal hypersensitivity following scaling and root planing. The experimental group (15 patients) was treated with low-energy-level diode laser at each site of dentinal hypersensitivity following scaling and root planning. The control group (15 patients) received topical fluoride treatment (protective varnish for desensitization). All the patients were treated at baseline visit, and then at day 2 and 4 after the initial treatment; the pain was subjectively assessed by the patients as strong, medium, medium low, low, or no pain. Total absence of the dental hypersensitivity was reported in 26.66% of the examined group even after the second visit, compared to the control group where complete resolution of the hypersensitivity was not present after the second visit in any of the treated cases. Complete absence of pain was achieved in 86.6% of patients treated with laser and only in 26.6% in the fluoride treated group, after the third visit. Based on our findings, we conclude that low-energy biostimulative laser treatment can be successfully used for treatment of dental hypersensitivity following scaling and root planing.
- Published
- 2010
- Full Text
- View/download PDF
36. Diabetics on dialysis in the Republic of Macedonia: A nationwide epidemiological study.
- Author
-
Polenakovic M, Sikole A, Nikolov IG, Georgiev D, Selim G, Dzekova-Vidimliski P, Gelev S, Amitov V, Oncevski A, Severova G, Pavleska S, Poposki A, Kovaceska V, Alceva M, Zdravkovska V, Antararov R, Dimitrov S, Janakievska P, Damjanovski M, Karceva Sarajlija E, Velinova B, Ivanovski K, Panova B, Neskovski J, Jovcevski D, Zafiroska M, Mat R, Filipovik R, Sela L, and Lamova K
- Subjects
- Aged, Ambulatory Care Facilities statistics & numerical data, Female, Humans, Male, Middle Aged, Republic of North Macedonia epidemiology, Diabetic Nephropathies epidemiology, Renal Dialysis statistics & numerical data
- Abstract
Background: Incidence increase of diabetes mellitus (DM) has taken epidemic proportions in the world. Diabetic nephropathy (DN) is a most serious complication, taking a leading place as a factor in the progression of chronic kidney disease (CKD). Dialysis treatment of these patients is complex, expensive, and exerts an excessive burden on the health budgets of the affected countries., Methods: We performed a nationwide precise observational study with the aim of analysing diabetics on dialysis in dialysis centres throughout the Republic of Macedonia (RM) in 2002 and in 2006; to compare the results from patients records; and to gather data on the epidemiology, clinical characteristics and complications of diabetes type 1 (DM1) and diabetes type 2 (DM2)., Results: The prevalence of HD patients in RM was 1114 vs 1074 in 2002 and 2006, respectively. Of these, 109 (9.78%) vs. 115 (10.71%) had DM in 2002 and 2006, respectively. The percentage of diabetics on dialysis between different centers varied between 3% to 21% vs. 2.4% to 22.07% in 2002 and 2006, respectively. The mean age of the patients was 58+/-10.29 vs. 56.5+/-10.71 in 2002 and 2006, respectively. Patients with DM1 were 19 (17.43%) vs. 15 (13.04%) and with DM2 were 90 (82.57%) vs. 100 (86.96%) in 2002 and 2006, respectively. 28 (25.68%) vs. 31 (26.96%) patients were on oral anti-diabetic drugs and 62 (57.21%) vs. 69 (60%) patients were on insulin in 2002 and 2006, respectively. Mean age of DM1 patients was 47+/-11.6 y. vs. 45+/-7.32 y. respectively and of DM2 was 60.37+/-8.33 y. vs. 61.14+/-10.23 y., in 2002 and 2006, respectively. Mean time of insulin treatment was 9.5+/-6.63 y. vs. 10.85+/-9.29 y. in 2002 and 2006. Mean Body Mass Index (BMI) was 26.4 vs. 23.49+/-4.74 kg/m2 in DM1 and 25.5 vs. 24.77+/-3.70 kg/m2 in DM2 patients in 2002 and 2006, respectively. Thrombosis of first arteriovenous fistulae (AVF) occurred in 41% vs. 25.22% in 2002 and 2006, respecttitvely. Hepatitis C virus (HCV) infection was confirmed in 57% vs. 44% of DM patients in 2002 and 2006, respectively. Most common co-morbidity in patients was hypertension, 91% vs. 80.87% in 2002 and 2006, respectively., Conclusion: The number of diabetics on dialysis in the Republic of Macedonia did not increase in the period from 2002 to 2006. In DM2 diabetics on dialysis the frequency of complications is higher and time on dialysis is shorter than in DM1 patients. Early detection of diabetic nephropathy by primary care physicians as well as collaborative treatment by diabetologists, nephrologists, cardiologists and ophthalmologists before and during dialysis are important for improvement of treatment and survival of diabetic patients on dialysis.
- Published
- 2010
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.